Search

everythinglearnresearchcommunity

for

Search:↓

Adiponectin may help hair grow based on lab tests.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Prostaglandins may protect hair follicles during chemotherapy.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Adiponectin reduces inflammation and bone loss in joint replacements.

Cellulite may be linked to low adiponectin, isotretinoin with UVB can treat psoriasis effectively, permanent alopecia post-chemotherapy resembles a unique hair loss, deodorants may cause fragrance allergies, desmoplastic melanoma is becoming more common, and intensive UVB treatment can give long-term psoriasis remission.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

More young women are getting diagnosed with PCOS, which can lead to other health problems, but early treatment can help.

The case emphasizes the need for careful screening in children for insulin resistance and related conditions.

Tumescent liposuction reduces waist and hip size but doesn't significantly change metabolic markers, though it may slightly improve blood pressure and certain protein levels.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Balding people may have higher heart disease risk.

Hair loss in young men in Central India is linked to severe heart disease.

Obesity is linked to more severe hair loss in adult men and to excess hair growth, but its effects on hair conditions are complex and need more research.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

Lower SHBG levels may increase the risk of PCOS.